Role of Cytochrome P450 2C9 in COVID-19 Treatment: Current Status and Future Directions
Description
The major human liver drug metabolising cytochrome P450 (CYP) enzymes are downregulated during inflammation and infectious disease state, especially during coronavirus disease 2019 (COVID-19) infection. The influx of proinflammatory cytokines, known
